Markus Meier News Today

Open access notables Back in April of 2020 Chi Xu et al. captivated some public attention with their paper Future of the human climate niche,  which explained a reasonable case for its startling conclusion about routine habitability of large parts of our planet now supporting dense populations. Now come the same researchers along with added talent to refine and extend those results, and the news isnt getting better. Quantifying the human cost of global warming paints a grim p...

Goldman bankers got less money but it wasnt entirely Goldmans doing.

Why do most people in Switzerland live in rented accommodation?

Zürich (ots) - Die Versprechungen zur Kostenfolge des CO2-Gesetzes durch den Bund vermochten diesmal nicht zu verfangen. Für eine Mehrheit der Stimmbevölkerung ist klar, dass neue Vorschriften und Zwänge

Adam KlasfeldMay 18th, 2021, 2:29 pm Former pharmaceutical executive Martin Shkreli points as he exits the courthouse after the jury issued a verdict in his case at the U.S. District Court for the Eastern District of New York, Aug. 4, 2017 in the Brooklyn borough of New York City. The Federal Trade Commission accused disgraced pharmaceutical executive Martin Shkreli on Tuesday of having destroyed evidence relevant to a lawsuit that could lead to his lifetime ban from the industry. Regulators ...

© Drew Angerer/Getty Images Finger-pointer Martin Shkreli Fending off a possible lifetime ban from the pharmaceutical industry, Martin Shkreli must prepare for a two-day deposition inside a federal prison in Allenwood, Pennsylvania, where he is serving a seven-year sentence for securities fraud. The Federal Trade Commission and seven state attorneys general will take turns grilling Shkreli about whether he conspired behind bars to jack up the price of the live-saving drug Daraprim, whose 40...

A Judge Fast-Tracked Martin Shkreli’s Grilling in Case That Could Get Him Banned for Life from Drug Industry—Here’s Why the Timing Matters Adam Klasfeld Fending off a possible lifetime ban from the pharmaceutical industry, Martin Shkreli must prepare for a two-day deposition inside a federal prison in Allenwood, Pennsylvania, where he is serving a seven-year sentence for securities fraud. The Federal Trade Commission and seven state attorneys general will take turns grill...

Adam KlasfeldDec 22nd, 2020, 4:34 pm Fending off a possible lifetime ban from the pharmaceutical industry, Martin Shkreli must prepare for a two-day deposition inside a federal prison in Allenwood, Pennsylvania, where he is serving a seven-year sentence for securities fraud. The Federal Trade Commission and seven state attorneys general will take turns grilling Shkreli about whether he conspired behind bars to jack up the price of the live-saving drug Daraprim, whose 40-fold price hike earned...